BUY Hyundai Motor India — Manas Jaiswal
byManas JaiswalHorizon: 1 year2 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Hyundai Motor India reported its highest-ever monthly sales of 77,916 units in September 2026, representing a 10.8% year-on-year growth, driven by both domestic and export performance.
BSE · Company Update·1 Oct · 1w ago
Hyundai Motor India reported its highest-ever monthly sales of 77,916 units in September 2026, representing a 10.8% year-on-year growth.
NSE · Press Release·1 Oct · 1w ago
CAFE-III Norms: Citi Favours Maruti Suzuki, M&M, Hyundai; BofA Sees Tata Motors Best Placed
NewsNdtv-Profit·1 Oct · 1w ago
October Car Launches: Hyundai Bayon, Elevate Facelift Among 9 Models to Watch — Full List
NewsNdtv-Profit·30 Sept · 1w ago
Hyundai Motor India shares rebound after 4-day slide: What’s driving the stock price rise? Buy or book profits?
NewsLivemint·25 Sept · 2w ago
As NSE lists, a look at debut performances of India’s largest IPOs
NewsHbl·24 Sept · 2w ago
Hyundai Motor India confirms analyst meet with JP Morgan on Sep 24
NewsGoogle News·18 Sept · 3w ago
NSE IPO GMP at 12% as stock exchange announces price band, key dates. 10 things to know
NewsEt-Markets·11 Sept · 4w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Hyundai Motor India
- SELL — Amit Seth22 Oct 2026 · Same day · target ₹1,870 · Expired
- BUY — Ashish Bahety, Profitmart Securities16 Oct 2026 · ~2 weeks · target ₹2,060 · SL hit
- BUY — Siddharth Rai Mangala13 Oct 2026 · Same day · target ₹2,040 · SL hit
- BUY — Prakash Gaba13 Oct 2026 · Same day · target ₹2,020 · SL hit
- BUY — Ashish Bahety, Profitmart Securities13 Oct 2026 · Same day · target ₹2,020 · Expired
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

